---
figid: PMC5543131__41467_2017_289_Fig5_HTML
figtitle: Differentially active pathways across pan-urologic genomic subtypes
organisms:
- Homo sapiens
- Hylobates sp.
- Mus musculus
- Erythroxylum coca
- Transposon gamma-delta
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC5543131
filename: 41467_2017_289_Fig5_HTML.jpg
figlink: /pmc/articles/PMC5543131/figure/Fig5/
number: F5
caption: Differentially active pathways across pan-urologic genomic subtypes. a Across
  the genomic subtypes, heat map represents differential aggregate expression of mRNAs
  associated with metabolism pathways, along with expression of metabolism-related
  proteins (using values normalized within cancer type; gray, no data; GNG, gluconeogenesis).
  Pathway diagram represents core metabolic pathways, with differential expression
  patterns comparing tumors in groups c5, c8, or TGCT.c9 (subset c9 of TGCT type)
  with tumors in groups RCC.c6 (c6 of KIRC or KICH type), c1, or TGCT.c4, respectively
  (red, significantly higher in c5/c8/TGCT.c9). b Across the genomic subtypes, heat
  map represents differential aggregate expression of mRNAs associated with hypoxia,
  EMT, MAPK, NRF2-ARE, and cyclin D1 pathways, along with a proteomic MAPK signature
  (using values normalized within cancer type). Pathway diagrams represent relationships
  between the above pathways–, , , with differential expression patterns comparing
  tumors in groups c5, c8, or c9 with tumors in groups c7, c1, or c2, respectively
  (red, significantly higher in c5/c8/c9). c Across the genomic subtypes, heat map
  represents differential mRNA and protein features involved with Hippo pathway. Pathway
  diagrams represent differential expression patterns comparing tumors in groups c2,
  c4, or c5 with tumors in groups c9, c9, or c6, respectively (red, significantly
  higher in c2/c4/c5). See also Supplementary Fig.
papertitle: Pan-urologic cancer genomic subtypes that transcend tissue of origin.
reftext: Fengju Chen, et al. Nat Commun. 2017;8:199.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5835187
figid_alias: PMC5543131__F5
figtype: Figure
redirect_from: /figures/PMC5543131__F5
ndex: 468d2642-deaf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5543131__41467_2017_289_Fig5_HTML.html
  '@type': Dataset
  description: Differentially active pathways across pan-urologic genomic subtypes.
    a Across the genomic subtypes, heat map represents differential aggregate expression
    of mRNAs associated with metabolism pathways, along with expression of metabolism-related
    proteins (using values normalized within cancer type; gray, no data; GNG, gluconeogenesis).
    Pathway diagram represents core metabolic pathways, with differential expression
    patterns comparing tumors in groups c5, c8, or TGCT.c9 (subset c9 of TGCT type)
    with tumors in groups RCC.c6 (c6 of KIRC or KICH type), c1, or TGCT.c4, respectively
    (red, significantly higher in c5/c8/TGCT.c9). b Across the genomic subtypes, heat
    map represents differential aggregate expression of mRNAs associated with hypoxia,
    EMT, MAPK, NRF2-ARE, and cyclin D1 pathways, along with a proteomic MAPK signature
    (using values normalized within cancer type). Pathway diagrams represent relationships
    between the above pathways–, , , with differential expression patterns comparing
    tumors in groups c5, c8, or c9 with tumors in groups c7, c1, or c2, respectively
    (red, significantly higher in c5/c8/c9). c Across the genomic subtypes, heat map
    represents differential mRNA and protein features involved with Hippo pathway.
    Pathway diagrams represent differential expression patterns comparing tumors in
    groups c2, c4, or c5 with tumors in groups c9, c9, or c6, respectively (red, significantly
    higher in c2/c4/c5). See also Supplementary Fig.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PGLS
  - G6PD
  - UBL4A
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - HK1
  - KCNA4
  - KLK1
  - HOOK1
  - TAC4
  - HK3
  - KLK3
  - HOOK3
  - C5
  - C6
  - PGD
  - PHGDH
  - C3
  - C7
  - C9
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - C2
  - GPI
  - GNPDA1
  - RPE
  - RPIA
  - PFKL
  - TALDO1
  - PFKP
  - FASN
  - ACACA
  - BMS1
  - ACACB
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PFKM
  - ALDOA
  - TKT
  - DDR2
  - TPI1
  - GAPDH
  - GAPDHP44
  - PGK1
  - PGK2
  - PGK1P2
  - PGM2
  - PGM1
  - ENO2
  - PSAT1
  - ENO1
  - ENO3
  - PSPH
  - PKM
  - PKLR
  - SHMT1
  - SDS
  - SBDS
  - SHMT2
  - SDSL
  - LDHC
  - LDHD
  - LDHA
  - SLC25A1
  - LDHB
  - DLD
  - FAM3A
  - DLAT
  - PDHA1
  - PDHB
  - PDC
  - PNKD
  - MDH1
  - ACO2
  - IDH2
  - PDP1
  - PLPP6
  - ME1
  - PCDHB16
  - MDH2
  - PDP2
  - FH
  - OGDH
  - PDK1
  - PDPK1
  - PDK2
  - SDHB
  - SDHC
  - LOC642502
  - SDHD
  - PDK3
  - PDK4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - HIF1A
  - CCND1
  - ITK
  - SLC22A3
  - GABPA
  - NFE2L2
  - KEAP1
  - CUL3
  - STING1
  - NF2
  - WWC1
  - SAV1
  - LATS1
  - LATS2
  - YAP1
  - TAFAZZIN
  - WWTR1
  - .na.character
  - Pgls
  - G6pdx
  - Hk2
  - Hk1
  - Hk3
  - Pgd
  - Ptgdr
  - Phgdh
  - Pfdn4
  - Oog1
  - Gpi1
  - Gnat2
  - Rpe
  - Rpia
  - Pfkl
  - Taldo1
  - Pfkp
  - Fasn
  - Acc
  - Pfkm
  - Aldoa
  - Tkt
  - Tpi1
  - Gapdh
  - Pgk1
  - Pgk2
  - Pgm2
  - Pgm1
  - Eno2
  - Prkaa1
  - Psat1
  - Eno1
  - Eno1b
  - Eno3
  - Psph
  - Pkm
  - Shmt1
  - Sds
  - Sbds
  - Shmt2
  - Sdsl
  - Ldhc
  - Ldhd
  - Hps3
  - Ldha
  - Slc25a1
  - Ldhb
  - Dld
  - Dlat
  - Pdha1
  - Pdhb
  - Pdc
  - Mdh1
  - Me1
  - Aco2
  - Idh2
  - Pdp1
  - Tcf12
  - Mdh2
  - Pdp2
  - fh
  - Ogdh
  - Pdk1
  - Pdpk1
  - Pdk2
  - Sdhb
  - Sdhc
  - Sdhd
  - Pdk3
  - Pdk4
  - Hif1a
  - Ccnd1
  - Itk
  - Slc22a3
  - Nfe2l2
  - Keap1
  - Cul3
  - Nf2
  - Wwc1
  - Sav1
  - Lats1
  - Lats2
  - Yap1
  - Tafazzin
  - Wwtr1
  - pgls
  - g6pd
  - hk2
  - hk1
  - c5
  - c6
  - pgd
  - c4
  - c9
  - gpia
  - gpib
  - rpe
  - rpia
  - taldo1
  - fasn
  - acaca
  - pfkma
  - aldoaa
  - tktb
  - gapdh
  - gapdhs
  - pgk1
  - pgm2
  - pgm1
  - eno2
  - phgdh
  - psat1
  - eno1a
  - eno3
  - psph
  - pkma
  - shmt1
  - shmt2
  - sdsl
  - ldhd
  - napbb
  - ldha
  - slc25a1a
  - ldhba
  - dld
  - dlat
  - pdha1a
  - pdha1b
  - pdhb
  - pdca
  - mdh1ab
  - mdh1aa
  - aco2
  - idh2
  - pdp1
  - me1
  - mdh2
  - pdp2
  - ogdha
  - pdk1
  - pdk2b
  - sdhb
  - sdhc
  - sdhdb
  - pdk3a
  - pdk4
  - hif1ab
  - ccnd1
  - nfe2l2a
  - keap1a
  - cul3a
  - nf2b
  - wwc1
  - sav1
  - lats1
  - lats2
  - yap1
  - tafazzin
  - 3-phosphoglycerate
  - 2-phosphoglycerate
  - gluconolactone
  - 3-phosphohydroxypyruvate
  - 1,3-bisphosphoglycerate
  - Fructose 1,6-bisphosphate
  - Ribulose
  - Fatty Acid
  - Fatty acid
  - Fatty acids
  - Fructose
  - gluconate
  - Glucose
  - Glyceraldehyde
  - Glycine
  - Isocitrate
  - Malonyl-CoA
  - Oxaloacetate
  - Pentose Phosphate
  - pentose
  - phosphate
  - phosphate phosphate
  - Phosphoenolpyruvate
  - Pyruvate
  - Serine
  - Glutamate
  - Lactate
  - Glycogen storage disease
---
